2-(Arylsulfonyl)oxetanes have been prepared as new structural motifs of interest for medicinal chemistry. These are designed to fit within fragment space and be suitable for screening in fragment based drug discovery, as well as being suitable for further elaboration or incorporation into drug-like compounds. The oxetane ring is constructed through an efficient C-C bond forming cyclisation which allows the incorporation of a wide range of aryl-sulfonyl groups. Furthermore, biaryl-containing compounds can be accessed through Suzuki-Miyaura coupling from halogenated derivatives. With a number of oxetane containing fragment compounds available, their pH stability was assessed, indicating good half-life values for mono-substituted aryl sulfonyl oxetanes across the pH range (1 to 10). Solubility and metabolic stability data is also reported. Finally, the conformation of the fragments is assessed computationally, providing an indication of possible binding orientations.
Introduction
Recent years have seen significant interest in the preparation of new chemical motifs for medicinal chemistry. 1 New motifs, including scaffolds and isosteres, can access new areas of chemical space and confer improved physicochemical properties, as well as intellectual property advantages when incorporated into target molecules. 2 We are interested in new chemical motifs for incorporation into drug-like compounds, which themselves also provide interesting fragments for fragment based drug discovery (FBDD), to be screened in their own right. FBDD has become a well-established and important approach to the development of new drugs and lead compounds.
3 An important advantage of fragment screening is the improved coverage of available chemical space offered by screening smaller molecules. 4, 5 The small size of fragments means that hits are likely to provide desirable starting points for a medicinal chemistry programme, to allow increases in MW and lipophilicity during optimisation of compound properties. 6, 7 To maximise coverage of chemical space, library design will consider many parameters. Within these, the Astex guidelines for fragments are often adhered to (Rule-of-3: MW <300, clogP ≤3, number of H-bond donors/acceptors ≤3), 8 though increased numbers of H-bond acceptors can aid solubility and provide additional binding elements. 9 Recent literature has called for an increase in the proportion of sp 3 rich fragments and their reduction in planarity. 10 This is because of observations that more sp 3 -rich molecules and aliphatic heterocycles can offer improved levels of success through development, relative to highly aromatic compounds. 11, 12 In addition, more sp 3 rich fragments may offer the potential for an improved hit rate in challenging biological targets such as protein-protein interactions (PPI). 13, 4 Although there remains debate over the advantages of "3-D fragments", there is significant interest to develop synthetic methods towards novel small non-planar fragments that access new chemical space. 2, 4, 7 In this context, we considered that novel substituted oxetanes could provide interesting chemical motifs and fragments. 14, 15 The oxetane motif is found in a variety of natural products and biologically active compounds ( Figure  1A ). 16 However, the recent increased interest in applying oxetanes in medicinal chemistry follows studies by Carreira and co-workers, in which the incorporation of 3,3-disubstituted oxetanes in place of gem-dimethyl groups was studied ( Figure  1B ). It was demonstrated that this use of oxetanes as replacement groups could impart improved physicochemical properties to drug-like compounds, without a significant increase in molecular weight. 18a Carreira extended this approach to use oxetanes as replacements for carbonyl groups, 18,1d with the oxetane providing comparable H-bonding properties, and recently oxetanes have been introduced in peptide mimics.
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Similarly, Carreira has subsequently developed several novel spirocyclic systems containing oxetanes, e.g. as replacements for a morpholine group ( Figure 1B) . 20 Following these advances, the appearance of oxetanes in medicinal chemistry has seen a notable increase, with particular aims of improving solubility or metabolic stability of drug-like compounds. 21, 22, 23 We recently communicated our initial studies into the synthesis of a series of novel 2-sulfonyl oxetanes 1a-d, designed to possess attractive characteristics as fragments for fragment based drug discovery (Figure 2 ). The incorporation of the small and polar oxetane heterocycles and the sulfonyl group provides desirable molecular weight and lipophilicity properties for fragments, and affords potential sites for binding interactions. Furthermore, we intended the functionality to facilitate further derivatisation for fragment growth or incorporation into larger compounds. Here we report our full studies into the synthesis of a wide array of 2-sulfonyl oxetanes, as well as derivatisation of the initial fragments maintaining the intact oxetane ring. We also report studies relevant to their potential and properties as fragments, indicating their stability to a range of pH conditions as well as indications of metabolic stability, solubility and calculated conformational features.
Results and Discussion

Synthesis of 2-(arylsulfonyl)oxetane derivatives
The synthesis of the oxetane motif remains a challenge due to the poor thermodynamics and kinetics of cyclisation to form 4-membered rings. The most widely used synthetic approaches to oxetanes involve C-O bond formation, often via intramolecular alkylation of a hydroxyl group, by a number of methods. 24, 25 These approaches were not suitable for the proposed sulfonyl oxetane compounds due to rapid elimination from the required α-hydroxy sulfonyl intermediates. Studies into displacing the leaving group adjacent to the sulfonyl group with a primary alcohol were similarly unsuccessful. Therefore, a different approach was required to access the proposed 2-sulfonyl oxetanes, for which we examined a C-C bond forming cyclisation approach (Scheme 1). 14, 15, 26 We envisaged that deprotonation next to the sulfone would provide a more reactive carbanion (vs an oxy-anion) that may facilitate cyclisation to the 4-membered ring.
Scheme 1. Carbon--carbon bond forming approach to 2--aryl sulfonyl oxetanes.
To commence the synthesis towards the precursor for cyclisation, of general structure 2, we required chloromethylsulfides 5a-k (Scheme 2). Chloromethyl phenyl sulfide 5a was commercially available and used as supplied. Most other examples were prepared by chlorination of the aryl methyl sulfide with NCS (1.1 equiv), in either CCl 4 27 or latterly with DCE, which was equally efficient. Filtration through silica, eluting with CH 2 Cl 2 , gave the sulfides in high yield and purity without further purification. For pyridyl substrate 5d, the chloromethyl sulfide was obtained in one step by alkylation of mercaptopyridine 4d with NaH and chloroiodomethane in DMF. 28 Chloromethyl sulfides 5 were then used to alkylate ethylene glycol. Ethylene glycol was employed as a solvent, which avoided double alkylation and provided S,O-acetals 6a-k. Tosylation of the primary alcohol followed by oxidation with excess mCPBA to the corresponding sulfones afforded the cyclisation precursors 2 in high yields. Optimisation of the C-C bond forming cyclisation was performed on compound 2b.
14 Initially sulfone 2b was deprotonated with a variety of bases; freshly made LiHMDS was optimal. The deprotonation and cyclisation occurred efficiently at 0 ºC. The order of addition of reactants was important; when LiHMDS was added to a solution of the sulfone it gave a marked increase in yield when compared to adding sulfone 2b to a solution of LiHMDS. Decreasing the 
Yield 2 (over 2 steps)
NCS, rt, 14 -19 h CCl 4 or ClCH 2 CH 2 Cl NaH, ClCH 2 I, DMF, -5 °C, 1 h, 45 min reaction time to 1 h and the equivalents of base to 1.1 afforded the optimum cyclisation conditions. Under these conditions, a 93% isolated yield was obtained on a 6 mmol scale, providing >1g of the sulfonyl oxetane fragment 1b (Scheme 3).
These conditions (1.1 equiv LiHMDS, 0 ºC, 1 h) were applied to sulfones 2a,c-k to afford the resulting 2-sulfonyl oxetanes in yields from 46-95% (Scheme 3). The cyclisation was successful with a variety of aromatic groups of varying size and electronics. A phenyl, para-tolyl, para-chloro phenyl and 2-pyridine ring were all high yielding under the optimised conditions 1a-d. Substitution at the ortho-and meta-positions of the aromatic ring were also successful 1e-g. As well as chloro substituents, both the fluoro and bromo substrates, 1h and 1i, were obtained in high yields (83% and 86%). The introduction of halogen substituents at all positions provides opportunities for further derivatisation of the sulfonyl oxetane. Both electron withdrawing and electron donating substrates were successful 1j and 1k. Each of the compounds prepared (Scheme 3) fit well into fragment space in terms of molecular weight (MW) and lipophilicity values (cLogP). Furthermore they present a number of H-bond acceptors, generally <4 as is appropriate for additional binding elements and further points for derivatisation.
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Scheme 3. Library of 2--sulfonyl oxetane fragments synthesised via an intramolecular C-C bond forming cyclisation.
As new motifs we were interested in methods for the incorporation of the 2-sulfonyl oxetanes into larger compounds, and as fragments we desired methods for their growth into leadlike and drug-like compounds were they to be a hit. With this in mind, an important aspect of the design of these fragments was to allow their further derivatisation. Initially, functionalisation on the intact oxetane ring via lithiation followed by electrophilic trapping was investigated, to generate 2,2-disubstituted oxetanes (Scheme 4). This deprotonation and electrophilic trapping was achieved under two sets of conditions appropriate for different electrophiles, both in excellent yields. When LiHMDS was employed the electrophile was added immediately. To maintain stability of the lithiated intermediate, the reagents were added at -78 ºC then warmed to 0 ºC for an in situ quench. However when nBuLi was used, to achieve full deprotonation the electrophile was added after a short deprotonation time and the reactions were maintained at -78 ºC. For compounds 8-12, purification on silica afforded reduced yields, and compounds required purification on basic alumina.
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Scheme 4. Functionalisation of 2--aryl sulfonyl oxetanes directly on the intact oxetane ring via lithiation. 14 We were interested in the viability of the 2-sulfonyl oxetane units as cross-coupling partners, to access functionalised biaryl systems. This was realised through Suzuki-Miyaura crosscoupling using Pd(OAc) 2 with Buchwald's SPhos ligand (Scheme 5). The para-chloro phenyl substrate 1c was successfully coupled with a variety of boronic acids, both electron withdrawing and electron donating to afford biaryls 13-16.
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Under these cross-coupling conditions, the halide and boronic acid were heated in water/dioxane at 65 ºC in the presence of K 2 CO 3 ; it was interesting to note that no degradation or ring opening of the oxetane was observed. The para-bromo phenyl sulfonyl oxetane 1i was also coupled with 4-cyanophenylboronic acid and 4-(hydroxymethyl)-phenylboronic acid in good yields, installing further reactive handles. Pleasingly both meta and ortho chlorides 1g and 1f were also successfully cross-coupled with 4-methoxyphenyl-boronic acid 
under the same reaction conditions to afford biaryl compounds 19 and 20, demonstrating how the 2-sulfonyl oxetane fragments could be derivatised in a variety of directions (Scheme 5).
Studies into the Stability of Sulfonyl Oxetanes
Having accessed a large variety of 2-sulfonyl-oxetanes we were interested to understand more about their desirability as fragments, in particular their stability under acidic conditions. Initial observations on stability to storage showed that all of the oxetane compounds were stable when kept under argon at -20 ºC. Oxetanes 1a-d were stored under argon at -20 ºC for >12 months and samples of fragments 1b and 1d were also stored at room temperature without any additional precautions for >3 months with no observable degradation. Similarly, biaryl oxetanes 13 and 16 were stable when stored under argon at -20 ºC for at least 8 months and at rt for at least 3 months. On the other hand, functionalised oxetanes 8 and 9, which are alkylated directly on the oxetane ring, underwent an unexpected rearrangement when stored at room temperature for more than 24 hours. While stable at -20 ºC for >2 months without degradation, 8 and 9 underwent rearrangement to quantitatively afford the corresponding β-sulfonyl ketones 21 and 22 at higher temperatures. The proposed mechanism is shown in scheme 6. With the increased steric demands of the α-alkylated derivatives we hypothesise that the sulfonyl group was lost to afford a tertiary carbocationic intermediate, possibly stabilised by the adjacent oxygen. Subsequent ring opening by attack of the sulfonyl group would afford the observed product. Consequently, these 2-alkylated 2-sulfonyl oxetanes were excluded from further stability studies and were considered to be less viable as fragments. A selection of mono-substituted sulfonyl oxetanes was subjected to pH stability studies. The solution stability of compounds 1a-c, 1h and 1k as well as biaryls 13 and 16 were assessed by incubating each compound (10 µM) for 15 hours at 70 ºC at pH 1, 4, 6, 8 and 10 in buffers containing 5% v/v 2-methoxyethanol. 32 Analysis was performed at regular intervals by LC-UV-MS. Half-lives were measured at 70 ºC then predicted at 25 ºC calculated using a factor of two for the reduction in rate for every 10 degree reduction in temperature (generally regarded as a worst case scenario). The extrapolated half-lives at 25 ºC are shown in table 1. a Half life calculated at 25 ºC, extrapolated from data measured at 70 ºC using a two-fold reduction in rate for every 10 degree drop in temperature.
For all compounds tested, 1a-c,h,k and 13 and 16, good half-lives were observed across the pH range, with each compound showing a similar trend. In particular it was notable that there was no significant acid sensitivity; decomposition pathways could be envisaged under acidic conditions through the protonation and ring opening of the oxetane, or through protonation of the sulfonyl group and expulsion of aryl sulfinic acid (similar to the first step of the proposed rearrangement in scheme 6). Despite this possibility, the half-lives at pH 1 were comparable to those under neutral conditions in most cases.
The fate of the compounds under the assay conditions was not conclusive from the MS study. One pathway for decomposition was likely to have been hydrolysis to the parent sulfonic acid, as indicated in Scheme 7 for the chlorinatedsubstrate 1c. This would give rise to a [M-H] -signal, which was observed during the mass spectrometry studies.
Scheme 7. One possible pathway for decomposition during the stability studies.
Comparing entries 1, 2 and 5 (table 1), it was apparent that the half-lives increased as the aromatic group became more electron rich. This would be consistent with a pathway for decomposition involving a nucleophilic attack at the sulfur center, promoted by the less electron rich/more electron withdrawing substituents on the aryl group. It could also be related to an increased α-acidity or leaving group ability of the more electron withdrawing substituents. This trend was further apparent with the biaryl compounds, 13 and 16. In general the half-lives were comparable to the phenyl derivative, however the more electron rich methoxy-substituted biaryl had a longer half-life under all pH conditions, compared to biphenyl 13 (entries 6 and 7, table 1).
The logD 7.4 was measured for a small selection of the compounds and indicated the hydrophilic nature of these fragments. As can be seen from table 2, there is not a good correlation with clogP. Additionally, the solubility of compounds 1d and 16 was assessed in aqueous phosphate buffer at pH 7.4 after 24 hours at 25 ºC, however, given the lipophilicity and molecular weight of these fragments, these values were disappointingly low, especially for the pyridyl substrate. Further work exploring the possible hydrogen bonding and solvation of these fragments would be required to fully understand these observations. Finally for compound 1d, the intrinsic clearance in rat hepatocytes was measured. The value of 2.8 µl/min/1E6 cells reflects low turnover as would be expected for a fragment of low lipophilicity, and indicates no inherent liability associated with the fragment in terms of metabolism.
Conformational Analysis
A potentially desirable feature of the 2-sulfonyl oxetanes is the presence of few rotatable bonds, with only rotation around the oxetane-sulfonyl bond possible. In order to understand more about the conformation of these fragments and how they might bind to a potential target the conformational profile of the 2-(phenylsulfonyl)oxetane 1a was investigated by computational methods; a DFT relaxed coordinate scan was performed at B3LYP/6-31G9(d,p) level of theory with default implicit solvation in water (scrf = water). 33 The dihedral angle around the oxetane C-S bond was varied in 10-degree increments between 0 and 360 degrees. The resulting conformational profile is shown in figure 3 . There are three preferred conformations corresponding to the staggered conformation of all bonds; with maxima at the eclipsed conformations. Energy minima were observed corresponding to dihedral angles of 60, 180 and 300 degrees. Representations of the conformations with the lowest energy are shown in figure 3. The conformation with a 60 degree dihedral angle had the lowest energy presumably due to opposing dipoles as well as minimal steric interactions between the oxetane and phenyl ring. The barriers to rotation as well as the energy difference between the three staggered conformations were relatively low (maximum 4 kcalmol -1 ) so the fragment may adopt any of these three conformations.
The same process was performed for the 2-pyridyl substrate 1d. As there were two possible low energy orientations of the pyridyl ring, energies were calculated for each of these, (figure 4). Both orientations of the pyridyl group 1d-A and 1d-B had three preferred conformations when altering the dihedral angle around the oxetane-C-S bond; similar to those seen for 2-(phenylsulfonyl)oxetane 1a. The minimal energy conformation correlates to the staggered configuration. Conformation 1d-A, with a dihedral angle of 60 degrees was the lowest energy conformation due to opposing dipoles of the pyridine/oxetane, as well as minimal steric hindrance. However, the barrier to rotation was again low. The preferred conformation of 2-(2-methylbenzenesulfonyl)-oxetane 1e, was also investigated. The calculations were performed for both orientations of the methyl group. The lowest energy conformation had a dihedral angle of 60 degrees, which we postulate results from a favourable intramolecular Van der Waals interaction between a proton on the benzylic CH 3 and the oxetane oxygen (figure 5). 
Conclusions
In summary we have successfully synthesised a wide array of novel 2-sulfonyl oxetanes that conform well to fragment criteria. These have been further functionalised in a variety of directions via lithiation and Suzuki cross-couplings, as would be appropriate for fragment hits. We have studied their stability and are pleased to show the fragments are stable to basic and more pleasingly acidic conditions. However the derivatised fragments, alkylated on the oxetane ring, undergo a rearrangement at room temperature. Finally calculations have been performed to understand the preferred conformations of a range of these fragments. These understandings enhance the desirability of 2-sulfonyl oxetanes as new motifs for incorporation into medicinal chemistry programs or for use as fragments in FBDD.
